搜索结果: 1-12 共查到“基础医学 vaccine”相关记录12条 . 查询时间(0.022 秒)
Expression and Purification of the Recombinant Cytochrome P450 CYP141 Protein of Mycobacterium Tuberculosis as a Diagnostic Tool and Vaccine Production
Gene Expression Cytochrome P450 Enzyme System Mycobacterium Tuberculosis
2015/11/6
Background: Tuberculosis (TB) is regarded as a health problem worldwide, particularly in developing countries. Mycobacterium tuberculosis (M. tuberculosis) is the cause of this disease. Approximately ...
Antibody's unusual abilities might inspire vaccine strategies
Antibody's unusual abilities inspire vaccine strategies
2015/5/25
The recent discovery of a novel antibody that works in an unusual way might inspire ideas for designing more effective vaccines. Among the common pathogens that might be targeted ...
Cloning of the Recombinant Cytochrome P450 Cyp141 Protein of Mycobacterium tuberculosis as a Diagnostic Target and Vaccine Candidate
Cloning Cytochrome Mycobacterium Tuberculosis Diagnostic
2015/10/15
Background: Tuberculosis has been announced as a global emergency by World Health Organization and the second infectious agent of mortality worldwide. The general policy in the development of new vacc...
Safe strep throat vaccine closer to reality（图）
strep throat vaccine the human immune system
2014/7/4
Researchers are one step closer to developing a safe vaccine against strep throat, which is responsible for more than 700 million infections and 500,000 deaths each year.
A University of Queensland spin-off company is about to start clinical trials that could result in the prevention and treatment of genital herpes, a virus that affects hundreds of thousands of people,...
Merck partnership accelerates needle-free vaccine delivery
needle-free vaccine delivery health technology
2014/7/15
A University of Queensland invention that will deliver vaccines without the need for needles has struck a significant partnership with US-based pharmaceutical giant Merck, announced today.
A $15 million investment in a start-up company to advance research and development at UQ's Australian Institute for Bioengineering and Nanotechnology (AIBN) has won the 2012 Best Venture Capital Inves...
UniQuest, based at The University of Queensland’s St Lucia campus, has congratulated NanopatchTM vaccine technology developer Vaxxas Pty Ltd and its investors on winning the prestigious 2012 Best Vent...
Recombinant Cryptosporidium parvum p23 as a Candidate Vaccine for Cryptosporidiosis
Cryptosporidium parvum Expression vector pGEX-5X-2 recombinant protein P23 PCR RT-PCR Western blot Dot Blot
2009/12/14
Background: Cryptosporidium parvum is a ubiquitous protozoan, which develops within the microvillous membrane of enterocytes in a wide variety of vertebrates, including man. Cryptosporidiosis is an im...
Experimental Study of Interference Between Pertussis Antigens and Salk Poliomyelitis Vaccine
Experimental Study Interference Pertussis Antigens Salk Poliomyelitis Vaccine
2009/12/3
An interference is observed between whooping-cough antigens and Salk polioc vaccine even if the two components are mixed immediately before use. The phenomenon is more evident when flUlid antigens are...
Investigation (In Vivo and In Vitro) of Booster Dose Vaccine Requirement for Long-Term Protection against Hepatitis B Virus Infection
HBV vaccination long-term protection booster dose requirement immunological memory
2009/5/20
Aim: Studies have shown that no booster dose was required at least 10 to 15 years after a primary vaccination for individuals who developed protective anti-hepatitis B surface (anti-HBs) antibodies. I...
EFFECT OF IMMUNOMODULATOR DARAPRIM ON POTENTIATION OF VACCINE PROTECTION OF LEISHMANIA MAJOR IN BALB/c MICE
Daraprim VACCINE PROTECTION MMUNOMODULATOR
2010/5/4
In this study, a crude leishmanial antigen, was prepared by sonicating Leishmania major promastigotes used to induce immunity in BALB/c mice against cutaneous leishmaniasis. Correlation between the ro...